António Champalimaud Vision Award honors Gerrit Melles, Claes Dohlman
Click Here to Manage Email Alerts
The Champalimaud Foundation has recognized Gerrit Melles, MD, PhD, and Claes H. Dohlman, MD, PhD, with its 2022 Vision Award for their research and treatment of corneal diseases, according to a press release.
The António Champalimaud Vision Award — worth 1 million euros — is the largest award in the field of vision. In alternate years, it recognizes the work involved in the prevention of and fight against blindness and vision disorders, mainly in developing countries, or far-reaching scientific research in the area of vision.
“For many years, corneal injuries or disorders have been one of the leading causes of blindness across the world,” the foundation said in the release. “The two physician-scientists have decisively changed and accelerated the path to the treatment of these problems. A deeper understanding of the transparent outer layer of the eye, as well as the possibility of ensuring an improved and more cost-effective approach to corneal surgery and transplantation, are essential to tackle this plight.”
Melles, of the Netherlands Institute for Innovative Ocular Surgery, was recognized for his work in corneal surgery. The foundation said his alternative approaches have transformed the way surgery is performed around the world.
Dohlman, of Massachusetts Eye and Ear, Harvard Medical School Department of Ophthalmology, was recognized for his long-term research to develop an artificial cornea, which ultimately led to the development of the Boston keratoprosthesis.